Cempra announces Positive Results from Phase 3 Clinical Trial of Solithromycin Oral Capsules

January 5, 2015 12:43 PM

4 0

Cempra announces Positive Results from Phase 3 Clinical Trial of Solithromycin Oral Capsules

Global Phase 3 clinical trial of solithromycin oral capsules or Solitaire-Oral meant for patients suffering from community acquired bacterial pneumonia (CABP) turned out to be successful.

Cempra Inc. announced that the capsules have been able to meet both primary and secondary objectives. The capsule met the primary goal of statistical non-inferiority of early clinical response at 72 hours after the therapy was started.

Read more

To category page

Loading...